Transcatheter Mitral Valve Repair Using the Edge-to-Edge Clip

Charles B. Nyman, G. Burkhard Mackensen, Srdjan Jelacic, Stephen H. Little, Thomas W R Smith, Feroze Mahmood

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Percutaneous intervention for mitral valve (MV) disease has been established as an alternative to open surgical MV repair in patients with prohibitive surgical risk. Multiple percutaneous approaches have been described and are in various stages of development. Edge-to-edge leaflet plication with the MitraClip (Abbott, Menlo Park, CA) is currently the only Food and Drug Administration-approved device specifically for primary or degenerative lesions. Use of the edge-to-edge clip for secondary mitral regurgitation is currently under investigation and may result in expanded indications. Echocardiography has significantly increased our understanding of the anatomy of the MV and provided us with the ability to classify and quantify the associated mitral regurgitation. For percutaneous interventions of the MV, transesophageal echocardiography imaging is used for patient screening, intraprocedural guidance, and confirmation of the result. Optimal outcomes require the echocardiographer and the proceduralist to have a thorough understanding of intra-atrial septal and MV anatomy, as well as an appreciation for the key points and potential pitfalls of each of the procedural steps. With increasing experience, more complex valvular pathology can be successfully percutaneously treated. In addition to two-dimensional echocardiography, advances in three-dimensional echocardiography and fusion imaging will continue to support the refinement of current technologies, the expansion of clinical applications, and the development of novel devices.

Original languageEnglish (US)
Pages (from-to)434-453
Number of pages20
JournalJournal of the American Society of Echocardiography
Volume31
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Mitral Valve
Surgical Instruments
Mitral Valve Insufficiency
Echocardiography
Anatomy
Three-Dimensional Echocardiography
Equipment and Supplies
Transesophageal Echocardiography
United States Food and Drug Administration
Pathology
Technology

Keywords

  • 3D echocardiography
  • Interventional echocardiography
  • MitraClip
  • Percutaneous mitral valve repair

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Transcatheter Mitral Valve Repair Using the Edge-to-Edge Clip. / Nyman, Charles B.; Mackensen, G. Burkhard; Jelacic, Srdjan; Little, Stephen H.; Smith, Thomas W R; Mahmood, Feroze.

In: Journal of the American Society of Echocardiography, Vol. 31, No. 4, 01.04.2018, p. 434-453.

Research output: Contribution to journalReview article

Nyman, Charles B. ; Mackensen, G. Burkhard ; Jelacic, Srdjan ; Little, Stephen H. ; Smith, Thomas W R ; Mahmood, Feroze. / Transcatheter Mitral Valve Repair Using the Edge-to-Edge Clip. In: Journal of the American Society of Echocardiography. 2018 ; Vol. 31, No. 4. pp. 434-453.
@article{8160798c85d545caaecb24e7a55e4af8,
title = "Transcatheter Mitral Valve Repair Using the Edge-to-Edge Clip",
abstract = "Percutaneous intervention for mitral valve (MV) disease has been established as an alternative to open surgical MV repair in patients with prohibitive surgical risk. Multiple percutaneous approaches have been described and are in various stages of development. Edge-to-edge leaflet plication with the MitraClip (Abbott, Menlo Park, CA) is currently the only Food and Drug Administration-approved device specifically for primary or degenerative lesions. Use of the edge-to-edge clip for secondary mitral regurgitation is currently under investigation and may result in expanded indications. Echocardiography has significantly increased our understanding of the anatomy of the MV and provided us with the ability to classify and quantify the associated mitral regurgitation. For percutaneous interventions of the MV, transesophageal echocardiography imaging is used for patient screening, intraprocedural guidance, and confirmation of the result. Optimal outcomes require the echocardiographer and the proceduralist to have a thorough understanding of intra-atrial septal and MV anatomy, as well as an appreciation for the key points and potential pitfalls of each of the procedural steps. With increasing experience, more complex valvular pathology can be successfully percutaneously treated. In addition to two-dimensional echocardiography, advances in three-dimensional echocardiography and fusion imaging will continue to support the refinement of current technologies, the expansion of clinical applications, and the development of novel devices.",
keywords = "3D echocardiography, Interventional echocardiography, MitraClip, Percutaneous mitral valve repair",
author = "Nyman, {Charles B.} and Mackensen, {G. Burkhard} and Srdjan Jelacic and Little, {Stephen H.} and Smith, {Thomas W R} and Feroze Mahmood",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.echo.2018.01.012",
language = "English (US)",
volume = "31",
pages = "434--453",
journal = "Journal of the American Society of Echocardiography",
issn = "0894-7317",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Transcatheter Mitral Valve Repair Using the Edge-to-Edge Clip

AU - Nyman, Charles B.

AU - Mackensen, G. Burkhard

AU - Jelacic, Srdjan

AU - Little, Stephen H.

AU - Smith, Thomas W R

AU - Mahmood, Feroze

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Percutaneous intervention for mitral valve (MV) disease has been established as an alternative to open surgical MV repair in patients with prohibitive surgical risk. Multiple percutaneous approaches have been described and are in various stages of development. Edge-to-edge leaflet plication with the MitraClip (Abbott, Menlo Park, CA) is currently the only Food and Drug Administration-approved device specifically for primary or degenerative lesions. Use of the edge-to-edge clip for secondary mitral regurgitation is currently under investigation and may result in expanded indications. Echocardiography has significantly increased our understanding of the anatomy of the MV and provided us with the ability to classify and quantify the associated mitral regurgitation. For percutaneous interventions of the MV, transesophageal echocardiography imaging is used for patient screening, intraprocedural guidance, and confirmation of the result. Optimal outcomes require the echocardiographer and the proceduralist to have a thorough understanding of intra-atrial septal and MV anatomy, as well as an appreciation for the key points and potential pitfalls of each of the procedural steps. With increasing experience, more complex valvular pathology can be successfully percutaneously treated. In addition to two-dimensional echocardiography, advances in three-dimensional echocardiography and fusion imaging will continue to support the refinement of current technologies, the expansion of clinical applications, and the development of novel devices.

AB - Percutaneous intervention for mitral valve (MV) disease has been established as an alternative to open surgical MV repair in patients with prohibitive surgical risk. Multiple percutaneous approaches have been described and are in various stages of development. Edge-to-edge leaflet plication with the MitraClip (Abbott, Menlo Park, CA) is currently the only Food and Drug Administration-approved device specifically for primary or degenerative lesions. Use of the edge-to-edge clip for secondary mitral regurgitation is currently under investigation and may result in expanded indications. Echocardiography has significantly increased our understanding of the anatomy of the MV and provided us with the ability to classify and quantify the associated mitral regurgitation. For percutaneous interventions of the MV, transesophageal echocardiography imaging is used for patient screening, intraprocedural guidance, and confirmation of the result. Optimal outcomes require the echocardiographer and the proceduralist to have a thorough understanding of intra-atrial septal and MV anatomy, as well as an appreciation for the key points and potential pitfalls of each of the procedural steps. With increasing experience, more complex valvular pathology can be successfully percutaneously treated. In addition to two-dimensional echocardiography, advances in three-dimensional echocardiography and fusion imaging will continue to support the refinement of current technologies, the expansion of clinical applications, and the development of novel devices.

KW - 3D echocardiography

KW - Interventional echocardiography

KW - MitraClip

KW - Percutaneous mitral valve repair

UR - http://www.scopus.com/inward/record.url?scp=85042351439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042351439&partnerID=8YFLogxK

U2 - 10.1016/j.echo.2018.01.012

DO - 10.1016/j.echo.2018.01.012

M3 - Review article

C2 - 29482977

AN - SCOPUS:85042351439

VL - 31

SP - 434

EP - 453

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

SN - 0894-7317

IS - 4

ER -